Debt-to-equity of CITIUS ONCOLOGY, INC. from 30 Jun 2025 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's debt by its shareholder equity.
- Summary
-
CITIUS ONCOLOGY, INC. quarterly Debt-to-equity in x history and change rate from 30 Jun 2025 to 31 Dec 2025.
- CITIUS ONCOLOGY, INC. Debt-to-equity for the quarter ending 31 Dec 2025 was 1.3x.
Debt-to-equity, Quarterly (x)
CITIUS ONCOLOGY, INC. Quarterly Debt-to-equity (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 1.3x | 31 Dec 2025 | ||
| Q3 2025 | 1.43x | 30 Sep 2025 | ||
| Q2 2025 | 1.3x | 30 Jun 2025 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.